Author

Andrea Lenartova

Oslo University HospitalORCID 0000-0001-8166-4404Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Organism:human· 2 Approach:statistical model· 2 Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Approach:machine learning (classical)· 1

Frequent Co-Authors

Yngvar FløisandiD· 2 shared Andrea M. Brodersen· 1 shared Aram Nikolai AnderseniD· 1 shared Benedicte Sjo TislevolliD· 1 shared Bjørn Tore GjertseniD· 1 shared Dagim Shiferaw TadeleiD· 1 shared Dimitrios KleftogiannisiD· 1 shared Emmanuel GriessingeriD· 1 shared

Activity by Year

2022-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 27 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersBioinformatics

Yngvar FløisandORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Automated cell type annotation and exploration of single-cell signalling dynamics using mass cytometry

Dimitrios Kleftogiannis, Sonia Gavasso, Benedicte Sjo Tislevoll, Nisha K. van der Meer, Inga K. F. Motzfeldt, Monica Hellesøy, Stein‐Erik Gullaksen, Emmanuel Griessinger, Oda Helen Eck Fagerholt, Andrea Lenartova, Yngvar Fløisand, Jan Jacob Schuringa, Bjørn Tore Gjertsen, Inge Jonassen

This paper introduces a bioinformatics framework for automated cell type annotation and patient stratification using CyTOF data, showing improved sensitivity and specificity and predictive survival analysis in leukemia.

iScience · Jun 12, 2024Peer-reviewedBioinformatics

Clinical Forecasting using Ex Vivo Drug Sensitivity Profiling of Acute Myeloid Leukemia

Aram Nikolai Andersen, Andrea M. Brodersen, Pilar Ayuda Durán, Laure Piechaczyk, Dagim Shiferaw Tadele, Lizet Baken, Julia Fredriksen, Mia Stoksflod, Andrea Lenartova, Yngvar Fløisand, Jorrit M. Enserink

This study evaluates ex vivo drug sensitivity profiling in AML patients to predict survival and chemotherapy response, showing its robustness in mapping treatment response signatures.

bioRxiv · Oct 11, 2022 · PreprintBioinformatics